- Report
- May 2020
- 173 Pages
Global
From €3448EUR$3,600USD£2,936GBP
- Report
- May 2020
- 79 Pages
Middle East, Africa
From €1437EUR$1,500USD£1,223GBP
- Report
- May 2020
- 79 Pages
Asia Pacific
From €1437EUR$1,500USD£1,223GBP
- Report
- May 2020
- 79 Pages
Europe
From €1437EUR$1,500USD£1,223GBP
- Report
- May 2020
- 73 Pages
North America
From €1437EUR$1,500USD£1,223GBP
- Report
- February 2020
- 231 Pages
Global
From €3448EUR$3,600USD£2,936GBP
- Report
- February 2020
- 94 Pages
Europe
From €1437EUR$1,500USD£1,223GBP
- Report
- September 2019
- 70 Pages
Global
From €3113EUR$3,250USD£2,651GBP
- Report
- January 2024
- 94 Pages
Global
From €3500EUR$3,915USD£3,085GBP
- Report
- September 2021
- 212 Pages
Global
From €3555EUR$3,712USD£3,028GBP
- Report
- February 2024
- 180 Pages
Global
From €5267EUR$5,499USD£4,485GBP
The Hormone Therapy market is a subset of the Endocrine and Metabolic Disorders Drugs market. It includes drugs used to treat conditions related to hormones, such as diabetes, thyroid disorders, and menopause. Hormone Therapy drugs are used to replace hormones that are not being produced in sufficient amounts by the body, or to block the action of hormones that are overproduced. These drugs are typically administered orally, through injections, or through topical creams.
Hormone Therapy drugs are used to treat a variety of conditions, including infertility, polycystic ovary syndrome, and growth hormone deficiency. They are also used to treat certain types of cancer, such as prostate cancer. Hormone Therapy drugs are often used in combination with other treatments, such as chemotherapy or radiation therapy.
Some of the companies in the Hormone Therapy market include Pfizer, Novo Nordisk, Merck, Sanofi, and Eli Lilly. Show Less Read more